Stoke Therapeutics Inc
STOK·Stocks·Biotechnology·United States·Nasdaq·USD
Price
$25.61
Today
-1.5%
YTD
-19.1%
About
Stoke Therapeutics is an early-stage biopharmaceutical company operating internationally. The company works to develop novel antisense oligonucleotide medicines which are designed to treat the underlying causes of serious genetic diseases. Founded in 2014, it has headquarters in Bedford, Massachusetts andtrades under the ticker STOKon the NASDAQ GS stock market. Invest in STOK stock to increase your eToro portfolio's diversity.
Price chart
Closing price history for STOK (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Financial insights
Valuation
P/E (TTM)-7.60
P/S (TTM)61.31
P/B (TTM)4.63
Market cap$1.65B
Cap tierSmall-cap
Industry avg P/E-1.99
Profitability
Gross margin84.67%
EBIT margin-809.69%
Net margin-660.78%
ROE-61.10%
ROA-53.41%
Earnings & Revenue
Revenue (TTM)$27.59M
Revenue growth (1Y)-86.2%
EPS (TTM)-$3.37
Free cash flow$-180.68M
Total debt$2.68M
Dividends & Risk
Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)1.26
Employees170
Next earnings3 Nov '26
Trade history
Closed trades
0
Realized return
+0.0%
No stored closed trades exist for this instrument yet.